Inside Hospitals' Digital Command Centers
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
During the winter of 2023, staff at Children's Mercy Kansas City were waiting for the "surge": a dreaded period when viral illnesses like influenza and RSV abound, leading to an increase in hospital admissions.
But as the winter bled into 2024, it became clear that something had changed. Children were still getting sick and requiring advanced medical care. However, staff at Children's Mercy weren't "feeling the angst" like they had in years past, according to Dr. Jennifer Watts, the hospital's associate chief medical officer of acute care and inpatient operations.
The difference, Watts said, came from technology. That was the hospital's first year using GE HealthCare's Command Center software, a product that allows it to digitally monitor care delivery and track patients' progress throughout their stay.
It's like the "NASA" control hub for the health system, Watts told Newsweek. During the first winter partnering with GE, Children's Mercy staff began asking, "Is the surge here?"
"They just didn't feel it," Watts said. "We were able to prepare. We were able to have [sufficient] staff present. We got rid of the scramble that typically occurs when you don't prepare for things."
Hospital staff inside Children's Mercy Kansas City's Patient Progression Hub, which uses GE Healthcare Command Center technology to paint a real-time picture of hospital happenings.
Hospital staff inside Children's Mercy Kansas City's Patient Progression Hub, which uses GE Healthcare Command Center technology to paint a real-time picture of hospital happenings.
Children's Mercy Kansas City Patient Progression Hub
Children's Mercy is one of 300 hospitals around the world that use GE's Command Center technology. As hospitals across the U.S. face rising demand for their services—driven, in part, by sicker patients and an aging population—many are turning to these digital "command centers" to improve operational efficiency and polish the patient experience.
Before developing a Patient Progression Hub, driven by GE's tech, Children's Mercy was still dealing with inefficient and outdated processes, according to Watts. Different departments were playing "phone tag" with one another to move patients through the hospital. Information was not centralized, and it was common to see staff with packets of papers in front of them, pinning memos on bulletin boards and communicating with fax machines.
Within seven months of implementing the Command Center technology, the hospital saw an 86 percent reduction in admission delays and cut avoidable bed days by 24 percent—creating capacity for 300 more medical-surgical patients without expanding its facility.
The tech sits atop hospitals' preexisting systems, like staffing platforms and electronic health records (EHRs), to generate a comprehensive, real-time picture of the hospital's caseload and available resources.
"The software really helps connect the strategy to the day-to-day operations," Bree Bush, general manager of GE's Command Center, told Newsweek.
Kristie Barazsu is the president and COO of Duke Health Lake Norman Hospital in Mooresville, North Carolina, and oversees patient flow for Duke Health, which stood up Command Center in 2019. During COVID-19, the health system could use the technology to understand where positive patients were located and deploy personal protective equipment (PPE) from its logistics center.
Command Center also utilizes predictive analytics to help hospitals plan for the future. Duke uses it to forecast the area's census, analyzing overall demand by unit, patient population and acuity.This information has informed the health system's staffing plan, allowing it to reduce reliance on costly, temporary travel labor—and reducing labor expenses by approximately $40 million to date, according to Barazsu.
Rather than viewing the hospitals within Duke's system as independent entities, a tech Command Center has enabled leadership to get the full picture, she added. The system can now move patients from one hospital to another more quickly, allowing it to free up bed space and accept more transfers from other health systems.
"We're not relying on word of mouth or pagers or systems that don't work well," Barazsu told Newsweek. "There's one source of truth."
Staff coordinate care inside UMass Memorial Health's new Digital Hub.
Staff coordinate care inside UMass Memorial Health's new Digital Hub.
UMass Memorial Health
While some health systems are partnering with a tech provider like GE, others are developing internal solutions to manage demand—and to keep tabs on a broadening menu of digital services.
UMass Memorial Health has been on the forefront of the digital revolution, according to Dr. Eric Alper, its vice president, chief quality and chief clinical informatics officer. The health system was an early adopter of electronic intensive care unit (eICU) technology, which allows ICU staff to virtually connect with a critical care physician on overnight shifts.
But a lot has changed since the advent of eICU tech about two decades ago, Alper told Newsweek. UMass Memorial used to run the service from a basement. Eventually it was supporting 150 critical care beds across the enterprise, and it was time for an upgrade.
The health system recently stood up a new Digital Hub, a 20,000-square-foot home for its eICU services, and several other virtual programs, including interpreter services, remote video monitoring, mobile integrated health, "ED at Home," primary care and the Transfer and Access Center, which coordinates the comings and goings of patients across UMass Memorial hospitals.
It might sound paradoxical to move virtual services to a physical location, but centralizing these operations has allowed for better communication, according to Alper, "We're collaborating more effectively by being in the same space, and that's allowing us to reduce some of the silos."
An urgent care provider conducts a virtual visit from Sanford Health's Virtual Care Center.
An urgent care provider conducts a virtual visit from Sanford Health's Virtual Care Center.
Sanford Health
Across the country in Sioux Falls, South Dakota, leaders at Sanford Health shared similar goals. The system stood up its own 60,000-square-foot Virtual Care Center in November, funded by a $350 million gift from its namesake Denny Sanford.
In April, Newsweek followed up on the initiative with Dr. Dave Newman, Sanford's chief medical officer of virtual care.
"One of the biggest things that the Virtual Care Center has done for Sanford is it emphasized the validity of virtual care and digital health," Newman told Newsweek. "The investment in the center and the space has shown that it's permanent, that this is what we're doing to help our patients, not just today or tomorrow but also 20 years from now."
For Watts at Children's Mercy Kansas City, one incident stands out as a testament to the tech Command Center's importance. Anytime there is a mass casualty event, nearby hospitals need to prepare 20 percent of their beds to accept new patients. That's a challenge for most hospitals, given their daily capacity constraints—but when a shooter opened fire on the Kansas City Chiefs' Super Bowl parade in February 2024, Children's Mercy was able to respond.
"This occurred a mile from our children's hospital, and we had no idea up front how many victims we would be receiving," Watts said, "but we were able to use the results of [Command Center predictive] modeling to get us to a point where, yes, we could take 20 percent of our beds and treat all of the victims that may be coming through our doors."
She's excited to see hospitals' virtual command centers and digital services grow, saying, "I think we have opened the Pandora's box here."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
5 hours ago
- Newsweek
Trump Brushes Off Major Success From First Term: 'Long Time Ago'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. President Donald Trump on Wednesday brushed off what is widely considered to be among the biggest uncontested successes of his first term while reacting to Health and Human Services Secretary Robert F. Kennedy Jr.'s move to pull $500 million in funding for next-generation mRNA-based vaccines to tackle viruses like Covid, H5N1 and the flu. "You were the driving force behind Operation Warp Speed, these mRNA vaccines that are the gold standard," a reporter asked Trump during a White House event on Wednesday. Operation Warp Speed was a 2020 public-private partnership, initiated by the first Trump administration, aimed at accelerating the development and distribution of a COVID-19 vaccine. At the time, it was almost universally accepted that an effective vaccine for the coronavirus was at least 18 months to two years away. Trump's operation did it in less than a year. "Now, your health secretary is pulling back all the funding for research, he's saying that the risks outweigh the benefits, which puts him at odds with the entire medical community, and with you," the reporter continued. "What's going on?" "Research on what?" Trump asked. "Into mRNA vaccines," she clarified. "Well, we're going to look at that," the president replied. "We're talking about it and they're doing a very good job, and you know, that is a pass." Trump went on to briefly acknowledge the success of Operation Warp Speed before dismissing it. "Operation Warp Speed was, whether you're a Republican or Democrat, considered one of the most incredible things ever done in this country," the president said. "The efficiency, the way it was done, the distribution, everything about it has been amazing." Then he added: "But, you know, that was now a long time ago. And we're onto other things, but we are speaking about it. We have meetings about it ... we're looking for other answers to other problems, to other sicknesses and diseases and I think we're doing really well." This is a breaking news story. Updates to follow.
Newsweek
7 hours ago
- Newsweek
French Bulldog's Reaction to Smelling Again After Surgery Delights Internet
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A video of a dog's reaction to smelling food for the first time after surgery melted people's hearts. A French bulldog named Kygo recently underwent surgery for a condition known as brachycephalic obstructive airway syndrome, or BOAS. The surgery helps alleviate the breathing difficulties of brachycephalic dog breeds—like English bulldogs, pugs and Boston terriers—an article from the Cornell University College of Veterinary Medicine said. The "nose job" surgery, as his owners called it on the dog's TikTok account @ involved opening his nostrils, reducing the soft palate and then removing laryngeal saccules to prevent further obstructions. And 24 hours postsurgery, Kygo's entire life changed as he rediscovered his sense of smell. In last week's TikTok video, which amassed over 7.5 million views and 1.6 million likes, Kygo intently sat next to his owners as they ate. He looked up with eyes full of amazement because the food smells wafted through his nostrils for the very first time since surgery. Screenshots from a TikTok video of a French bulldog smelling food for the first time after nose surgery. Screenshots from a TikTok video of a French bulldog smelling food for the first time after nose surgery. @ He wasn't begging for a nibble of their food, as many dogs might have done. Instead, he tilted his head higher, embracing all the delicious aromas in a new way he hadn't experienced before. His nostrils flared in and out in amazement. Now, he's a smelling machine and can't get enough whiffs of everything around him. Newsweek reached out to the owners via email for additional information and comment. What Do the Comments Say? With over 5,770 comments, the TikTok video started a debate among viewers. Many fell in love with Kygo's precious reaction, calling him the "goodest sniffer." "Sniffing in HD now," wrote a viewer, while another pointed out: "The way he looked at you after the first sniff was like, 'Omg, you right!'" A third user commented: "He looks like he's suspicious about his newfound sense of smell." However, others believed this clip shined a light on the dangers of breeding dogs. They claimed the surgery could have been avoided. "The fact we have to perform this surgery on some breeds in the first place is HIGHLY upsetting," a person said. The article from Cornell said BOAS is a genetic condition, and these dogs, which have difficulty breathing, require surgical therapy or have a hypoplastic trachea, should not be considered for breeding. Do you have funny and adorable videos or pictures of your pet you want to share? Send them to life@ with some details about your best friend, and they could appear in our Pet of the Week lineup.
Newsweek
11 hours ago
- Newsweek
Alzheimer's: Scientists Discover What Sparks Disease
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Lithium deficiency in the brain could be a cause of Alzheimer's disease—and a new potential target for treatment. Ten years in the making, this is the finding of researchers at Harvard Medical School who have revealed how lithium plays an essential role in brain function and may provide resistance against brain aging and Alzheimer's. Lithium is a chemical element, currently used as medicine to treat mood disorders like mania and bipolar disorder. "Most people associate lithium with psychiatric treatment. Our study shows, for the first time, that naturally occurring lithium plays a crucial role in maintaining brain health during aging—even at concentrations far below those used in clinical psychiatry," study authors Bruce Yankner and Liviu Aron told Newsweek. The findings are based on a series of experiments in mice and on analyses of human brain tissue and blood samples from individuals in various stages of cognitive health. Lithium carbonate tablet bottles on shelf. Lithium carbonate tablet bottles on shelf. Getty Images "We found that lithium is uniquely depleted in the brains of people with mild cognitive impairment—a precursor to Alzheimer's. This makes lithium deficiency one of the earliest biochemical signs of the disease, possibly years before clinical symptoms appear," the duo explained. "We also saw that higher endogenous lithium levels were associated with preserved cognitive function even in individuals without Alzheimer's. So, this isn't just about preventing disease—it's about supporting healthy brain aging in general. The new revelation helps to explain why some people with Alzheimer's-like abnormalities in the brain don't go on to develop the disease. While genetic and environmental factors play a role, scientists also haven't been able to suggest why some people with the same risk factors might develop it and others don't—until now. The scientists unearthed that lithium loss in the human brain is one of the earliest changes leading to Alzheimer's. In mice, meanwhile, similar lithium depletion accelerated brain pathology (disease or abnormality) and memory decline. They also found reduced lithium levels stemmed from binding to amyloid plaques (misfolded proteins found between nerve cells found in the brains of people with Alzheimer's) and impaired uptake in the brain. One pair of boxes shows fewer green amyloid clusters on the left and more on the right. Another pair of boxes shows a dim arc of purple and red tau on the left and a... One pair of boxes shows fewer green amyloid clusters on the left and more on the right. Another pair of boxes shows a dim arc of purple and red tau on the left and a brighter arc on the right. More Yankner Lab In their final set of experiments, they found a new lithium compound that avoids "capture" by amyloid plaques restored memory in mice. "In people that start experiencing memory loss, the so-called mild cognitive impairment, lithium gets trapped by amyloid plaques—reducing its availability just when it's most needed to protect against inflammation and neurodegeneration," Yankner and Aron explained. "This creates a self-perpetuating feedback loop of worsening pathology and accelerating disease progression and memory loss." This all ties together decades-long observations in patients and provides a new theory of the disease and strategy for early diagnosis, prevention and treatment, according to the researchers. Recently developed treatments that target amyloid beta (a key component of the amyloid plaques) typically don't reverse memory loss and only modestly reduce the rate of decline. "The idea that lithium deficiency could be a cause of Alzheimer's disease is new and suggests a different therapeutic approach," said Yankner in a statement. Researchers had previously found lithium to be the only metal that had markedly different levels across people with and without Alzheimer's at different stages. But Yankner added in a statement, "Lithium turns out to be like other nutrients we get from the environment, such as iron and vitamin C. "It's the first time anyone's shown that lithium exists at a natural level that's biologically meaningful without giving it as a drug." Previous population studies have shown that higher lithium levels in the environment, including in drinking water, tracked with lower rates of dementia. Woman hugging her elderly mother. Woman hugging her elderly mother. PIKSEL/Getty Images Yankner's team demonstrated in mice that lithium depletion isn't just linked to Alzheimer's, it actually helps drive it. This raises hope that one day lithium could be used to treat the disease in its entirety rather than focusing on a single factor like amyloid beta or tau (another Alzheimer's-associated protein), Yankner said. Crucially, the researchers discovered that as amyloid beta begins to form deposits in the early stages of dementia in both humans and mouse models, it binds to lithium, reducing lithium's function in the brain. The reduced levels of lithium affect all major brain cell types and, in mice, lead to changes similar to those seen in Alzheimer's disease, including memory loss. Treating mice with the most potent amyloid-evading compound, called lithium orotate, reversed Alzheimer's pathology, prevented brain cell damage and restored memory. While the findings need to be confirmed in humans through clinical trials, they suggest that measuring lithium levels could help screen for early Alzheimer's. They also highlight the importance of testing amyloid-evading lithium compounds for treatment or prevention. While other lithium compounds are already used to treat bipolar disorder and clinical depression, they are given at much higher concentrations that can be toxic to some people, the researchers flag. Yankner's team discovered lithium orotate is effective at one-thousandth that dose— enough to mimic the natural level of lithium in the brain. Mice treated for nearly their entire adult lives showed no evidence of toxicity, the study found. If further studies confirm these findings, the researchers say lithium screening through routine blood tests may one day offer a way to identify individuals at risk for Alzheimer's who would benefit from treatment to prevent or delay disease onset. "Our study adds to growing evidence that Alzheimer's may be preventable—with something as simple as keeping brain lithium at healthy levels as we age," said Yankner and Aron. "Clinical trials [on humans] could test the impact of low-dose supplementation on cognitive health and dementia risk." Before lithium is proved to be safe and effective in protecting against neurodegeneration in humans, Yankner emphasized that people should not take lithium compounds on their own. Do you have a health story to share with Newsweek? Do you have a question about Alzheimer's? Let us know via health@ Reference Aron, L., Ngian, Z. K., Qiu, C., Choi, J., Liang, M., Drake, D. M., Hamplova, S. E., Lacey, E. K., Roche, P., Yuan, M., Hazaveh, S. S., Lee, E. A., Bennett, D. A., & Yankner, B. A. (2025). Lithium deficiency and the onset of Alzheimer's disease. Nature.
